| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4131082 | Diagnostic Histopathology | 2014 | 9 Pages |
Abstract
Comprehensive gene expression and genetic analysis of lymphoma during the last decade has revealed activated signaling pathways that can be targeted with specific drugs. In addition, novel antibodies have been developed to specifically target lymphoma cells. This article reviews these recent developments and discusses the potential consequences for diagnosis of lymphoma.
Related Topics
Health Sciences
Medicine and Dentistry
Pathology and Medical Technology
Authors
Jan Delabie, Noah Kates Rose,